MAZUMDAR CLAIRE (Chief Executive Officer) sold 9.8% of their position (36.77K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $704.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0001628280-26-016874
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-36.77K
Net shares
Net seller
$704.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
36.77K acquired · 73.53K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+36.77K
Price / share
$3.79
Trade value
$139.34K
% of position
10.8%
3/9/2026
339.39K→376.16K
Common Stock
Direct
Shares
−36.77K
Price / share
$19.17
Trade value
$704.66K
% of position
9.8%
3/9/2026
376.16K→339.39K
Total
Net shares
+0.00
Net value
-$565.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | M · Option Exercise | +36.77K | $3.79 | $139.34K | 10.8% | 339.39K | 376.16K |
| Common Stock Direct | 3/9/2026 | S · Sale | −36.77K | $19.17 | $704.66K | 9.8% | 376.16K | 339.39K |
| Total | +0.00 | -$565.32K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
36.77K shares
Shares
−36.77K
Strike price
3.7898
Held after
191.11K
Exercisable
—
3/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock36.77K shares | 3/9/2026 | M · Option Exercise | −36.77K | 3.7898 | — | 191.11K |